xylazine has been researched along with Acute Kidney Injury in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapitsinou, PP | 1 |
| Jaffe, J | 1 |
| Michael, M | 1 |
| Swan, CE | 1 |
| Duffy, KJ | 1 |
| Erickson-Miller, CL | 1 |
| Haase, VH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Roxadustat Reduces the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting: a Multicenter, Randomized, Double-blind, Placebo-controlled Study[NCT05010460] | Phase 2 | 318 participants (Anticipated) | Interventional | 2021-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for xylazine and Acute Kidney Injury
| Article | Year |
|---|---|
Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Hydroxylation; Hy | 2012 |